Ten Years of Ocrelizumab in Relapsing Multiple Sclerosis: The OPERA I and II Randomized Clinical Trials. Hauser SL, Bar-Or A, Giovannoni G, Montalban X, et al. JAMA Neurol 2026 Oct 5:e263507. doi: 10.1001/jamaneurol.2026.3507.

Read + Share

Amedeo Smart

Independent Medical Education

Hauser SL, Bar-Or A, Giovannoni G, Montalban X, et al. Ten Years of Ocrelizumab in Relapsing Multiple Sclerosis: The OPERA I and II Randomized Clinical Trials. JAMA Neurol 2026 Oct 5:e263507. doi: 10.1001/jamaneurol.2026.3507.
PMID: 42832215